Global Hyperbilirubinemia Treatment Market Growth (Status and Outlook) 2023-2029

February 2023 | 88 pages | ID: GCA3DC6F9140EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

LPI (LP Information)' newest research report, the “Hyperbilirubinemia Treatment Industry Forecast” looks at past sales and reviews total world Hyperbilirubinemia Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Hyperbilirubinemia Treatment sales for 2023 through 2029. With Hyperbilirubinemia Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hyperbilirubinemia Treatment industry.

This Insight Report provides a comprehensive analysis of the global Hyperbilirubinemia Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hyperbilirubinemia Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Hyperbilirubinemia Treatment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hyperbilirubinemia Treatment and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hyperbilirubinemia Treatment.

The global Hyperbilirubinemia Treatment market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Hyperbilirubinemia Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Hyperbilirubinemia Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Hyperbilirubinemia Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Hyperbilirubinemia Treatment players cover Philips, GE Healthcare, Nice Neotech, Getinge Group and Solarc Systems, Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Hyperbilirubinemia Treatment market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type

• Phototherapy
• Exchange Transfusion
• Others

Segmentation by application

• Hospitals
• Clinics
• Home Care

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Philips
• GE Healthcare
• Nice Neotech
• Getinge Group
• Solarc Systems, Inc.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Hyperbilirubinemia Treatment Market Size 2018-2029
  2.1.2 Hyperbilirubinemia Treatment Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Hyperbilirubinemia Treatment Segment by Type
  2.2.1 Phototherapy
  2.2.2 Exchange Transfusion
  2.2.3 Others
2.3 Hyperbilirubinemia Treatment Market Size by Type
  2.3.1 Hyperbilirubinemia Treatment Market Size CAGR by Type (2018 VS 2022 VS 2029)
  2.3.2 Global Hyperbilirubinemia Treatment Market Size Market Share by Type (2018-2023)
2.4 Hyperbilirubinemia Treatment Segment by Application
  2.4.1 Hospitals
  2.4.2 Clinics
  2.4.3 Home Care
2.5 Hyperbilirubinemia Treatment Market Size by Application
  2.5.1 Hyperbilirubinemia Treatment Market Size CAGR by Application (2018 VS 2022 VS 2029)
  2.5.2 Global Hyperbilirubinemia Treatment Market Size Market Share by Application (2018-2023)

3 HYPERBILIRUBINEMIA TREATMENT MARKET SIZE BY PLAYER

3.1 Hyperbilirubinemia Treatment Market Size Market Share by Players
  3.1.1 Global Hyperbilirubinemia Treatment Revenue by Players (2018-2023)
  3.1.2 Global Hyperbilirubinemia Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Hyperbilirubinemia Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 HYPERBILIRUBINEMIA TREATMENT BY REGIONS

4.1 Hyperbilirubinemia Treatment Market Size by Regions (2018-2023)
4.2 Americas Hyperbilirubinemia Treatment Market Size Growth (2018-2023)
4.3 APAC Hyperbilirubinemia Treatment Market Size Growth (2018-2023)
4.4 Europe Hyperbilirubinemia Treatment Market Size Growth (2018-2023)
4.5 Middle East & Africa Hyperbilirubinemia Treatment Market Size Growth (2018-2023)

5 AMERICAS

5.1 Americas Hyperbilirubinemia Treatment Market Size by Country (2018-2023)
5.2 Americas Hyperbilirubinemia Treatment Market Size by Type (2018-2023)
5.3 Americas Hyperbilirubinemia Treatment Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Hyperbilirubinemia Treatment Market Size by Region (2018-2023)
6.2 APAC Hyperbilirubinemia Treatment Market Size by Type (2018-2023)
6.3 APAC Hyperbilirubinemia Treatment Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Hyperbilirubinemia Treatment by Country (2018-2023)
7.2 Europe Hyperbilirubinemia Treatment Market Size by Type (2018-2023)
7.3 Europe Hyperbilirubinemia Treatment Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Hyperbilirubinemia Treatment by Region (2018-2023)
8.2 Middle East & Africa Hyperbilirubinemia Treatment Market Size by Type (2018-2023)
8.3 Middle East & Africa Hyperbilirubinemia Treatment Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL HYPERBILIRUBINEMIA TREATMENT MARKET FORECAST

10.1 Global Hyperbilirubinemia Treatment Forecast by Regions (2024-2029)
  10.1.1 Global Hyperbilirubinemia Treatment Forecast by Regions (2024-2029)
  10.1.2 Americas Hyperbilirubinemia Treatment Forecast
  10.1.3 APAC Hyperbilirubinemia Treatment Forecast
  10.1.4 Europe Hyperbilirubinemia Treatment Forecast
  10.1.5 Middle East & Africa Hyperbilirubinemia Treatment Forecast
10.2 Americas Hyperbilirubinemia Treatment Forecast by Country (2024-2029)
  10.2.1 United States Hyperbilirubinemia Treatment Market Forecast
  10.2.2 Canada Hyperbilirubinemia Treatment Market Forecast
  10.2.3 Mexico Hyperbilirubinemia Treatment Market Forecast
  10.2.4 Brazil Hyperbilirubinemia Treatment Market Forecast
10.3 APAC Hyperbilirubinemia Treatment Forecast by Region (2024-2029)
  10.3.1 China Hyperbilirubinemia Treatment Market Forecast
  10.3.2 Japan Hyperbilirubinemia Treatment Market Forecast
  10.3.3 Korea Hyperbilirubinemia Treatment Market Forecast
  10.3.4 Southeast Asia Hyperbilirubinemia Treatment Market Forecast
  10.3.5 India Hyperbilirubinemia Treatment Market Forecast
  10.3.6 Australia Hyperbilirubinemia Treatment Market Forecast
10.4 Europe Hyperbilirubinemia Treatment Forecast by Country (2024-2029)
  10.4.1 Germany Hyperbilirubinemia Treatment Market Forecast
  10.4.2 France Hyperbilirubinemia Treatment Market Forecast
  10.4.3 UK Hyperbilirubinemia Treatment Market Forecast
  10.4.4 Italy Hyperbilirubinemia Treatment Market Forecast
  10.4.5 Russia Hyperbilirubinemia Treatment Market Forecast
10.5 Middle East & Africa Hyperbilirubinemia Treatment Forecast by Region (2024-2029)
  10.5.1 Egypt Hyperbilirubinemia Treatment Market Forecast
  10.5.2 South Africa Hyperbilirubinemia Treatment Market Forecast
  10.5.3 Israel Hyperbilirubinemia Treatment Market Forecast
  10.5.4 Turkey Hyperbilirubinemia Treatment Market Forecast
  10.5.5 GCC Countries Hyperbilirubinemia Treatment Market Forecast
10.6 Global Hyperbilirubinemia Treatment Forecast by Type (2024-2029)
10.7 Global Hyperbilirubinemia Treatment Forecast by Application (2024-2029)

11 KEY PLAYERS ANALYSIS

11.1 Philips
  11.1.1 Philips Company Information
  11.1.2 Philips Hyperbilirubinemia Treatment Product Offered
  11.1.3 Philips Hyperbilirubinemia Treatment Revenue, Gross Margin and Market Share (2018-2023)
  11.1.4 Philips Main Business Overview
  11.1.5 Philips Latest Developments
11.2 GE Healthcare
  11.2.1 GE Healthcare Company Information
  11.2.2 GE Healthcare Hyperbilirubinemia Treatment Product Offered
  11.2.3 GE Healthcare Hyperbilirubinemia Treatment Revenue, Gross Margin and Market Share (2018-2023)
  11.2.4 GE Healthcare Main Business Overview
  11.2.5 GE Healthcare Latest Developments
11.3 Nice Neotech
  11.3.1 Nice Neotech Company Information
  11.3.2 Nice Neotech Hyperbilirubinemia Treatment Product Offered
  11.3.3 Nice Neotech Hyperbilirubinemia Treatment Revenue, Gross Margin and Market Share (2018-2023)
  11.3.4 Nice Neotech Main Business Overview
  11.3.5 Nice Neotech Latest Developments
11.4 Getinge Group
  11.4.1 Getinge Group Company Information
  11.4.2 Getinge Group Hyperbilirubinemia Treatment Product Offered
  11.4.3 Getinge Group Hyperbilirubinemia Treatment Revenue, Gross Margin and Market Share (2018-2023)
  11.4.4 Getinge Group Main Business Overview
  11.4.5 Getinge Group Latest Developments
11.5 Solarc Systems, Inc.
  11.5.1 Solarc Systems, Inc. Company Information
  11.5.2 Solarc Systems, Inc. Hyperbilirubinemia Treatment Product Offered
  11.5.3 Solarc Systems, Inc. Hyperbilirubinemia Treatment Revenue, Gross Margin and Market Share (2018-2023)
  11.5.4 Solarc Systems, Inc. Main Business Overview
  11.5.5 Solarc Systems, Inc. Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Hyperbilirubinemia Treatment Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Phototherapy
Table 3. Major Players of Exchange Transfusion
Table 4. Major Players of Others
Table 5. Hyperbilirubinemia Treatment Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Hyperbilirubinemia Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Hyperbilirubinemia Treatment Market Size Market Share by Type (2018-2023)
Table 8. Hyperbilirubinemia Treatment Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Hyperbilirubinemia Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Hyperbilirubinemia Treatment Market Size Market Share by Application (2018-2023)
Table 11. Global Hyperbilirubinemia Treatment Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Hyperbilirubinemia Treatment Revenue Market Share by Player (2018-2023)
Table 13. Hyperbilirubinemia Treatment Key Players Head office and Products Offered
Table 14. Hyperbilirubinemia Treatment Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Hyperbilirubinemia Treatment Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Hyperbilirubinemia Treatment Market Size Market Share by Regions (2018-2023)
Table 19. Global Hyperbilirubinemia Treatment Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Hyperbilirubinemia Treatment Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Hyperbilirubinemia Treatment Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Hyperbilirubinemia Treatment Market Size Market Share by Country (2018-2023)
Table 23. Americas Hyperbilirubinemia Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Hyperbilirubinemia Treatment Market Size Market Share by Type (2018-2023)
Table 25. Americas Hyperbilirubinemia Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Hyperbilirubinemia Treatment Market Size Market Share by Application (2018-2023)
Table 27. APAC Hyperbilirubinemia Treatment Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Hyperbilirubinemia Treatment Market Size Market Share by Region (2018-2023)
Table 29. APAC Hyperbilirubinemia Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Hyperbilirubinemia Treatment Market Size Market Share by Type (2018-2023)
Table 31. APAC Hyperbilirubinemia Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Hyperbilirubinemia Treatment Market Size Market Share by Application (2018-2023)
Table 33. Europe Hyperbilirubinemia Treatment Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Hyperbilirubinemia Treatment Market Size Market Share by Country (2018-2023)
Table 35. Europe Hyperbilirubinemia Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Hyperbilirubinemia Treatment Market Size Market Share by Type (2018-2023)
Table 37. Europe Hyperbilirubinemia Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Hyperbilirubinemia Treatment Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Hyperbilirubinemia Treatment Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Hyperbilirubinemia Treatment Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Hyperbilirubinemia Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Hyperbilirubinemia Treatment Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Hyperbilirubinemia Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Hyperbilirubinemia Treatment Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Hyperbilirubinemia Treatment
Table 46. Key Market Challenges & Risks of Hyperbilirubinemia Treatment
Table 47. Key Industry Trends of Hyperbilirubinemia Treatment
Table 48. Global Hyperbilirubinemia Treatment Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Hyperbilirubinemia Treatment Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Hyperbilirubinemia Treatment Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Hyperbilirubinemia Treatment Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. Philips Details, Company Type, Hyperbilirubinemia Treatment Area Served and Its Competitors
Table 53. Philips Hyperbilirubinemia Treatment Product Offered
Table 54. Philips Hyperbilirubinemia Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. Philips Main Business
Table 56. Philips Latest Developments
Table 57. GE Healthcare Details, Company Type, Hyperbilirubinemia Treatment Area Served and Its Competitors
Table 58. GE Healthcare Hyperbilirubinemia Treatment Product Offered
Table 59. GE Healthcare Main Business
Table 60. GE Healthcare Hyperbilirubinemia Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. GE Healthcare Latest Developments
Table 62. Nice Neotech Details, Company Type, Hyperbilirubinemia Treatment Area Served and Its Competitors
Table 63. Nice Neotech Hyperbilirubinemia Treatment Product Offered
Table 64. Nice Neotech Main Business
Table 65. Nice Neotech Hyperbilirubinemia Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Nice Neotech Latest Developments
Table 67. Getinge Group Details, Company Type, Hyperbilirubinemia Treatment Area Served and Its Competitors
Table 68. Getinge Group Hyperbilirubinemia Treatment Product Offered
Table 69. Getinge Group Main Business
Table 70. Getinge Group Hyperbilirubinemia Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Getinge Group Latest Developments
Table 72. Solarc Systems, Inc. Details, Company Type, Hyperbilirubinemia Treatment Area Served and Its Competitors
Table 73. Solarc Systems, Inc. Hyperbilirubinemia Treatment Product Offered
Table 74. Solarc Systems, Inc. Main Business
Table 75. Solarc Systems, Inc. Hyperbilirubinemia Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. Solarc Systems, Inc. Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Hyperbilirubinemia Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Hyperbilirubinemia Treatment Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Hyperbilirubinemia Treatment Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Hyperbilirubinemia Treatment Sales Market Share by Country/Region (2022)
Figure 8. Hyperbilirubinemia Treatment Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Hyperbilirubinemia Treatment Market Size Market Share by Type in 2022
Figure 10. Hyperbilirubinemia Treatment in Hospitals
Figure 11. Global Hyperbilirubinemia Treatment Market: Hospitals (2018-2023) & ($ Millions)
Figure 12. Hyperbilirubinemia Treatment in Clinics
Figure 13. Global Hyperbilirubinemia Treatment Market: Clinics (2018-2023) & ($ Millions)
Figure 14. Hyperbilirubinemia Treatment in Home Care
Figure 15. Global Hyperbilirubinemia Treatment Market: Home Care (2018-2023) & ($ Millions)
Figure 16. Global Hyperbilirubinemia Treatment Market Size Market Share by Application in 2022
Figure 17. Global Hyperbilirubinemia Treatment Revenue Market Share by Player in 2022
Figure 18. Global Hyperbilirubinemia Treatment Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Hyperbilirubinemia Treatment Market Size 2018-2023 ($ Millions)
Figure 20. APAC Hyperbilirubinemia Treatment Market Size 2018-2023 ($ Millions)
Figure 21. Europe Hyperbilirubinemia Treatment Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Hyperbilirubinemia Treatment Market Size 2018-2023 ($ Millions)
Figure 23. Americas Hyperbilirubinemia Treatment Value Market Share by Country in 2022
Figure 24. United States Hyperbilirubinemia Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Hyperbilirubinemia Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Hyperbilirubinemia Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Hyperbilirubinemia Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Hyperbilirubinemia Treatment Market Size Market Share by Region in 2022
Figure 29. APAC Hyperbilirubinemia Treatment Market Size Market Share by Type in 2022
Figure 30. APAC Hyperbilirubinemia Treatment Market Size Market Share by Application in 2022
Figure 31. China Hyperbilirubinemia Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Hyperbilirubinemia Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Hyperbilirubinemia Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Hyperbilirubinemia Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Hyperbilirubinemia Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Hyperbilirubinemia Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Hyperbilirubinemia Treatment Market Size Market Share by Country in 2022
Figure 38. Europe Hyperbilirubinemia Treatment Market Size Market Share by Type (2018-2023)
Figure 39. Europe Hyperbilirubinemia Treatment Market Size Market Share by Application (2018-2023)
Figure 40. Germany Hyperbilirubinemia Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Hyperbilirubinemia Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Hyperbilirubinemia Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Hyperbilirubinemia Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Hyperbilirubinemia Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Hyperbilirubinemia Treatment Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Hyperbilirubinemia Treatment Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Hyperbilirubinemia Treatment Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Hyperbilirubinemia Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Hyperbilirubinemia Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Hyperbilirubinemia Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Hyperbilirubinemia Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Hyperbilirubinemia Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Hyperbilirubinemia Treatment Market Size 2024-2029 ($ Millions)
Figure 54. APAC Hyperbilirubinemia Treatment Market Size 2024-2029 ($ Millions)
Figure 55. Europe Hyperbilirubinemia Treatment Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Hyperbilirubinemia Treatment Market Size 2024-2029 ($ Millions)
Figure 57. United States Hyperbilirubinemia Treatment Market Size 2024-2029 ($ Millions)
Figure 58. Canada Hyperbilirubinemia Treatment Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Hyperbilirubinemia Treatment Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Hyperbilirubinemia Treatment Market Size 2024-2029 ($ Millions)
Figure 61. China Hyperbilirubinemia Treatment Market Size 2024-2029 ($ Millions)
Figure 62. Japan Hyperbilirubinemia Treatment Market Size 2024-2029 ($ Millions)
Figure 63. Korea Hyperbilirubinemia Treatment Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Hyperbilirubinemia Treatment Market Size 2024-2029 ($ Millions)
Figure 65. India Hyperbilirubinemia Treatment Market Size 2024-2029 ($ Millions)
Figure 66. Australia Hyperbilirubinemia Treatment Market Size 2024-2029 ($ Millions)
Figure 67. Germany Hyperbilirubinemia Treatment Market Size 2024-2029 ($ Millions)
Figure 68. France Hyperbilirubinemia Treatment Market Size 2024-2029 ($ Millions)
Figure 69. UK Hyperbilirubinemia Treatment Market Size 2024-2029 ($ Millions)
Figure 70. Italy Hyperbilirubinemia Treatment Market Size 2024-2029 ($ Millions)
Figure 71. Russia Hyperbilirubinemia Treatment Market Size 2024-2029 ($ Millions)
Figure 72. Spain Hyperbilirubinemia Treatment Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Hyperbilirubinemia Treatment Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Hyperbilirubinemia Treatment Market Size 2024-2029 ($ Millions)
Figure 75. Israel Hyperbilirubinemia Treatment Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Hyperbilirubinemia Treatment Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Hyperbilirubinemia Treatment Market Size 2024-2029 ($ Millions)
Figure 78. Global Hyperbilirubinemia Treatment Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Hyperbilirubinemia Treatment Market Size Market Share Forecast by Application (2024-2029)